Damion Wicker, M.D.
DW is a co-founder of Panorama and focuses primarily on life sciences
investments. Previously, DW was a Partner and co-head of the life sciences
practice at JPMorgan Partners. He joined JPMP in 1993. Previously, DW was
President of Adams Scientific and held positions with MBW Venture Partners
and Alexon, Inc. He was also a Commonwealth Fund Medical Fellow for the
National Institutes of Health. DW previously served on a variety of boards
including Innotech (NASDAQ:IIII) (acquired by J&J), dj Orthopedics
(NYSE:DJO) (acquired by ReAble Ortho), Eyetech Pharmaceuticals (NASDAQ:EYET)
(merged with OSI), Cadent Holdings (acquired by Align Technologies), Renovo
Limited (LSE:RNVO), Praecis (NASDAQ:PRCS), and Landec (NASDAQ:LNDC). He was
also involved with investments in Flamel (NASDAQ:FLML), Onyx (NASDAQ:ONXX),
Connetics (NASDAQ:CNCT), Kinetic Concepts (NYSE:KCI), and Illumina
(NASDAQ:ILMN). Dr. Wicker was a member of the NVCA Life Sciences Group Board
and The New York Bioscience Initiatives Board, and was previously an Advisor
to the Hospital for Special Surgery Ventures Investment Committee.
DW holds a B.S., with honors, from Massachusetts Institute of Technology, an
M.D. from the Johns Hopkins School of Medicine, and an M.B.A. from the
Wharton School of the University of Pennsylvania. He was previously on The Board of Trustees
of the New York Academy of Medicine and is currently a member of the Investment Committee
for the New York Academy of Medicine Endowment. He is also a member of the MIT
Corporate Development Committee.